Nov 15, 2026Oyster Therapeutics raises $60M for brain-penetrating small molecule degradersBrain-focused startup Oyster Therapeutics secured $60 million to advance its lead program targeting pathological tau in Alzheimer's disease, with Eli Lilly participating in the round.Nov 15, 2026·3 sources00
Apr 20, 2026Gut Microbiome Analysis Can Predict Parkinson's Disease Risk Before Symptoms AppearNew research led by University College London shows that analysis of gut microbes can reveal elevated Parkinson's disease risk before any symptoms develop, offering potential for early intervention.Apr 20, 2026·1 source00
Apr 11, 2026Experimental Parkinson's Drug Reduces Disease-Linked Protein by Up to 60% in First Human TrialAn experimental drug designed to silence a gene strongly linked to Parkinson's disease showed encouraging effects in reducing the target protein by up to 60% in a first-in-human clinical trial published in Nature Medicine.Apr 11, 2026·1 source00